MedTrace Logo

Growth and Tolerance of Young Infants Fed Infant Formula

NCT04105686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 366

Last updated 2021-01-25

No results posted yet for this study

Summary

This is a randomized, multicenter, controlled, double-blind, parallel study to evaluate growth and tolerance of healthy term infants fed milk-based infant formulas.

Conditions

  • Growth and Tolerance

Interventions

OTHER

Control Infant Formula

Ready to feed infant formula, feed ad libitum

OTHER

Experimental Infant Formula

Ready to feed infant formula, feed ad libitum

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Timberly Williams, PhD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2020-12-04
Completion
2020-12-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04105686 on ClinicalTrials.gov